Company Search:
Advanced Search
Sponsored Links
Grifols SA - ADR Company Snapshot
Grifols SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grifols SA with three other pharmaceutical manufacturers in North America: Eisai Company Limited (2019 sales of $5.79 billion of which 88% was Pharmaceutical Business), Zoetis Inc ($6.26 billion of which 51% was US), and Alexion Pharmaceuticals, Inc. ($4.95 billion of which 80% was Soliris).

Sales Analysis. Grifols SA reported sales of $5.70 billion for the year ending December of 2019. This represents an increase of 7.8% versus 2018, when the company's sales were $5.29 billion. This was the fourth straight year of sales growth at Grifols SA. Sales of Bio Supplies saw an increase that was more than double the company's growth rate: sales were up 51.4% in 2019, from $196.77 million to $297.93 million. Not all segments of Grifols SA experienced an increase in sales in 2019: sales of Others/raw Materials fell 3.6% to $25.51 million. (However, this segment's sales were only a very small portion of the company's overall sales). Grifols SA also experienced decreases in sales in Diagnostics (down 0.9% to $819.99 million) .
  Stock Performance Chart for Grifols SA - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 18.24
(Figures in U.S. Dollars)
1 Week -3.3%   13 Weeks -1.7%  
4 Weeks -7.6%   52 Weeks -17.2%  
Grifols SA - ADR Key Data:
  Ticker: GRFS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 5,699,061,865
(Year Ending Jan 2020).
Employees: 24,016
  Currency: U.S. Dollars Market Cap: 12,478,628,693
  Fiscal Yr Ends: December Shares Outstanding: 684,135,345
  Share Type: ORDINARY Closely Held Shares: 145,690,603
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.